08:01 EST Johnson & Johnson to acquire Halda Therapeutics for $3.05B in cash
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Bristol Myers to stop Phase 3 Librexia ACS trial of milvexian
- Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
- Scotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
- Johnson & Johnson initiated with an Outperform at Scotiabank
- enGene price target raised to $10 from $4 at UBS